S-Acetyl Glutathione and Performance Recovery in Soccer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-29
SponsorUniversity of Thessaly

About this trial

Soccer players display elevated inflammatory and oxidative stress markers combined with reduced soccer specific performance over a 72-hour period. However, in modern soccer, players participate very often in 2 or 3 matches within a week, with a recovery period of 72 hours between successive matches, that is insufficient to restore skeletal muscle homeostasis and performance. Of note, reduced glutathione (GSH) levels, a tripeptide consisting of the amino acids cysteine, glycine and glutamic acid, are substantially reduced during the 72-hour recovery period after a match because of the trauma-related acute inflammatory and oxidative stress response. GSH availability is a crucial regulator of cellular redox status, affecting numerous intracellular and physiological processes such as redox signalling, immunoregulation and muscle metabolism. Indeed, enhanced GSH availability following muscle damaging exercise has been shown to be beneficial for skeletal muscle and performance recovery by mitigating the inflammatory and oxidative stress response. Thus, the enhancement of GSH availability through dietary interventions would be a promising strategy to accelerate skeletal muscle and performance recovery following a soccer game. S-Acetyl Glutathione (SAG) is a glutathione precursor with enhanced absorption kinetics due to chemical S-acetylation of the thiol group on the cysteinyl amino acid of GSH and oral administration of SAG has been shown to be more effective in restoring intracellular glutathione levels compared to oral glutathione. The aim of this study is to (i) perform a pharmacokinetic assessment of 200 mg/day vs 500 mg/day of SAG during a 7-day supplementation period (pre-loading) and (ii) to establish the pharmacodynamic effect of the two dosages at 24, 48 and 72h following a 90-minute official soccer match.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

participation at elite (top three division leagues) for ≥ 4 years

no recent history of febrile illness, musculoskeletal problems and metabolic diseases

no consumption of medications and performance-enhancing supplements (including anti-inflammatory, antioxidants, vitamins and multivitamin supplements) for at least 6 months prior to the study

participation in at least 5 training sessions and 1 match per week

Disqualifiers

musculoskeletal injury

consumption of medication and performance-enhancing supplements

illness during the course of the study

loss of follow-up measurements

Trial design

Design model

Crossover

Treatments tested in this trial

  • 200 mg S-Acetyl Glutathione

    Dietary supplement

    Participants will be supplemented daily with 200 mg of S-acetyl glutathione, orally, over the 11-day experimental period.

  • 500 mg S-Acetyl Glutathione

    Dietary supplement

    Participants will be supplemented daily with 500 mg of S-acetyl glutathione, orally, over the 11-day experimental period.

  • Placebo Supplementation

    Dietary supplement

    Participants will be supplemented daily with placebo, orally, over the 11-day experimental period.

Treatment groups

20 Participants
are divided into 3 treatment groups
Group A: SAG-200 TrialExperimental treatment 1 intervention
Group B: SAG-500 TrialExperimental treatment 1 intervention
Group C: Placebo TrialPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in creatine kinase levels

Creatine kinase concentration will be measured in serum using a Clinical Chemistry Analyzer

Time frame
Day 1, day 7, day 9, day 10 and day 11
2

Change in myoglobin levels

Myoglobin concentration will be measured in serum using a Clinical Chemistry Analyzer

Time frame
Day 1, day 7, day 9, day 10 and day 11
3

Change in reduced glutathione

Reduced glutathione will be photometrically determined in red blood cell lysates using a spectrophotometer

Time frame
Day 1, day 7, day 9, day 10 and day 11
4

Change in oxidized glutathione

Oxidized glutathione will be photometrically determined in red blood cell lysates using a spectrophotometer

Time frame
Day 1, day 7, day 9, day 10 and day 11

Secondary outcomes

1

Change in total distance covered

Total distance (km) covered during training and match play will be monitored using Global Positioning System (GPS)

Time frame
Daily throughout the 11-day experimental period
2

Change in internal load

Heart rate during training sessions and the match will be monitored using heart rate monitors

Time frame
Daily throughout the 11-day experimental period
3

Change in dietary intake

Dietary intake will be assessed using diet recalls

Time frame
Daily throughout the 11-day experimental period
4

Change in time spent in moderate-to-vigorous physical activity

The time (minutes) spent in moderate-to-vigorous physical activity on a daily basis will be monitored using accelerometers

Time frame
Daily throughout the 11-day experimental period

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Thessaly

Lead sponsor

Lesaffre International

Collaborator

This trial is not recruiting at the moment. You can still explore other options: